Long Focus Capital Management, LLC Aura Biosciences, Inc. Transaction History
Long Focus Capital Management, LLC
- $2.88 Billion
- Q1 2025
A detailed history of Long Focus Capital Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 3,319,582 shares of AURA stock, worth $19.6 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
3,319,582
Previous 2,537,774
30.81%
Holding current value
$19.6 Million
Previous $20.9 Million
6.75%
% of portfolio
0.67%
Previous 0.71%
Shares
10 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.4MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$40.8 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$28.8 Million0.06% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$17.9 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$17.7 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.73MShares$16.1 Million0.7% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $173M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...